Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Cichutek

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Gene Therapy|August 18, 2001
Targeted gene transfer to lymphocytes using murine leukaemia virus vectors pseudotyped with spleen necrosis virus envelope proteinsM Engelstädter, C J Buchholz, M Bobkova, et al.
Intervirology|January 1, 1997
Increased serum and mRNA levels of RANTES associated with elevated levels of activated CD8+CD38+ T cells in HIV-1 infected individualsP Müller, M Engelstädter, A Werner, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 1997
Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cellsB S Schnierle, J Stitz, V Bosch, et al.
Gene Therapy|July 29, 2003
Directed evolution of retroviruses activatable by tumour-associated matrix metalloproteasesR M Schneider, Y Medvedovska, I Hartl, et al.
The Journal of General Virology|October 1, 1996
Replication and cytopathogenicity of human immunodeficiency virus type 1 (HIV-1)/simian immunodeficiency virus agm3 chimeric viruses in human and monkey cells: the 5' half of the HIV-1 genome is responsible for virus cytopathogenicityM Jin, E Ido, T Kuwata, et al.
Gene Therapy|February 18, 2005
Library-based selection of retroviruses selectively spreading through matrix metalloprotease-positive cellsI Hartl, R M Schneider, Y Sun, et al.
Human Gene Therapy|February 19, 2000
Targeting human T cells by retroviral vectors displaying antibody domains selected from a phage display libraryM Engelstädter, M Bobkova, M Baier, et al.
Journal of Virology|December 1, 1989
Molecularly cloned simian immunodeficiency virus SIVagm3 is highly divergent from other SIVagm isolates and is biologically active in vitro and in vivoM Baier, A Werner, K Cichutek, et al.
Virology|March 7, 2002
A novel lentivirus vector derived from apathogenic simian immunodeficiency virusJ Stitz, M D Mühlebach, U Blömer, et al.
Virology|February 9, 2000
MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patientsJ Stitz, S Steidl, H Merget-Millitzer, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Gene Therapy|August 18, 2001
Targeted gene transfer to lymphocytes using murine leukaemia virus vectors pseudotyped with spleen necrosis virus envelope proteinsM Engelstädter, C J Buchholz, M Bobkova, et al.
Intervirology|January 1, 1997
Increased serum and mRNA levels of RANTES associated with elevated levels of activated CD8+CD38+ T cells in HIV-1 infected individualsP Müller, M Engelstädter, A Werner, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 1997
Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cellsB S Schnierle, J Stitz, V Bosch, et al.
Gene Therapy|July 29, 2003
Directed evolution of retroviruses activatable by tumour-associated matrix metalloproteasesR M Schneider, Y Medvedovska, I Hartl, et al.
The Journal of General Virology|October 1, 1996
Replication and cytopathogenicity of human immunodeficiency virus type 1 (HIV-1)/simian immunodeficiency virus agm3 chimeric viruses in human and monkey cells: the 5' half of the HIV-1 genome is responsible for virus cytopathogenicityM Jin, E Ido, T Kuwata, et al.
Gene Therapy|February 18, 2005
Library-based selection of retroviruses selectively spreading through matrix metalloprotease-positive cellsI Hartl, R M Schneider, Y Sun, et al.
Human Gene Therapy|February 19, 2000
Targeting human T cells by retroviral vectors displaying antibody domains selected from a phage display libraryM Engelstädter, M Bobkova, M Baier, et al.
Journal of Virology|December 1, 1989
Molecularly cloned simian immunodeficiency virus SIVagm3 is highly divergent from other SIVagm isolates and is biologically active in vitro and in vivoM Baier, A Werner, K Cichutek, et al.
Virology|March 7, 2002
A novel lentivirus vector derived from apathogenic simian immunodeficiency virusJ Stitz, M D Mühlebach, U Blömer, et al.
Virology|February 9, 2000
MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patientsJ Stitz, S Steidl, H Merget-Millitzer, et al.
Pageof 6